Latest New Zealand News

Felix Group Holdings reminds shareholders that its Share Purchase Plan closes on 9 September, offering shares at a slight discount following a $16 million placement. Eligible investors in Australia and New Zealand have a final chance to participate without brokerage fees.

DGL Group Limited has issued a corrected FY25 financial presentation, revealing lower EBITDA and NPAT figures due to operational challenges and restructuring costs. Despite revenue growth, the company faces a modified audit opinion on inventory and outlines strategic cost-cutting and growth investments.

EMU NL has announced a $1.83 million non-renounceable entitlement offer to fund exploration at its Georgetown and Badja projects, while facing potential board upheaval at an upcoming general meeting.

iTech Minerals has announced a $2 million equity raise, including a $1 million Share Purchase Plan offering shares at a 14.2% discount to fund key mineral exploration projects and working capital.

Wesfarmers Limited has updated its dividend details, confirming a fully franked ordinary dividend of AUD 1.11 per share payable on 7 October 2025, with shareholders able to receive payments in AUD, NZD, or GBP.

Australian United Investment Company Limited has updated its dividend announcement to include the Dividend Reinvestment Plan issue price, confirming a fully franked total dividend of AUD 0.28 per share for the period ending June 2025.

Vicinity Centres has updated its dividend distribution details for the six months ending June 2025, including the Dividend Reinvestment Plan price and the NZD equivalent payout for New Zealand investors.

SunRice reported steady FY25 financials with improved profitability despite revenue pressure, while advancing its 2030 Growth Strategy amid industry headwinds and leadership transition.

Compumedics has secured FDA clearance for its single-use Somfit®D device, effectively doubling its addressable U.S. home sleep testing market to an estimated US$240 million annually. This milestone positions the company to capture significant market share with a dual-platform EEG-based solution.

Core Lithium has launched a $10 million Share Purchase Plan offering eligible shareholders the chance to buy new shares at the same price as a recent institutional placement, aiming to bolster working capital and support key project developments.

Control Bionics Limited has announced a 1-for-5 non-renounceable rights issue to raise up to $2.06 million, aiming to fund the commercial expansion of its NeuroStrip® device and operational growth. The offer is partially underwritten and open to eligible shareholders in Australia and New Zealand.

KMD Brands has launched a comprehensive transformation strategy aimed at unlocking brand potential and driving sustainable growth through cost reductions, product innovation, and digital acceleration.